Face skin diseases at women of fertile age
Year: 2020, volume 16 Issue: №1 Pages: 34-38
Heading: Dermatovenerology Article type: Original article
Authors: Baytyakov V.V., Taratynova A.l., Vlasova S.A.
Organization: Ogarev Mordovia State University
Heading: Dermatovenerology Article type: Original article
Authors: Baytyakov V.V., Taratynova A.l., Vlasova S.A.
Organization: Ogarev Mordovia State University
Summary:
Purpose: clinical and anamnestic characteristics of rosacea and perioral dermatitis in women of reproductive age. Material and Methods. 81 women (50 with rosacea and 31 with perioral dermatitis) from the age of 18 to 49 were examined. Clinical and anamnestic data were studied. Results. The incidence of rosacea in women increases by the end of the fertile period, while the peak of the incidence of perioral dermatitis is noted at the beginning of the fourth decade of life. Patients with rosacea, more often than with perioral dermatitis, have a family history with a predominance of maternal inheritance (p<0.001). They also have a significantly higher level of the accompanying pathology (p<0.05). In the formation of perioral dermatitis, the use of topical corticosteroids (38.7%) and the abuse of cosmetics (32.3%) play an undoubted role. In women of childbearing age, the prevalence of erythematous-telangiectatic subtype of rosacea (64.0%) is revealed, with a relatively low frequency (2.0%) of eye damage. In patients with perioral dermatitis revealed a more pronounced decrease in quality of life with no dependence on the severity of the skin process (p=0.046). Conclusion. The revealed clinical features of rosacea and perioral dermatitis indicate the nosological independence of these disorders with the dominating role in forming of rosacea — constitutional, and in perioral dermatitis — exogenous factors.
Keywords: clinical and anamnestic characteristics, perioral dermatitis, quality of life, rosacea, women of fertile age
Bibliography:
1. Smirnova EA, Olisova OYu, Kochergin NG. New combined topical therapy for refractory rosacea. Vestnik Dermatologii i Venerologii 2018; 94 (4): 21-9.
2. Potekaev NN, L'vov AN, Hlystova EA, et al. First experience of using ivermectin and brimonidine tartrate in patients with rosacea: case studies. The Russian journal of dermatology and venereology 2017; 16(2): 117-25.
3. Kyriakis КР, Palamaras I, Terzoudi S, et al. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005; 53 (5): 918-9. DOI: 10.1016/j. jaad. 2005.05.018.
4. Spoendlin J, Voegel JJ, Jick SS, et al. A study on the epidemiology of rosacea in the U. K. Br J Dermatol 2012; 167 (3): 598-605. DOI: 10.1111/j. 1365-2133.2012.11037. x.
5. Tan J, Schbfer H,Araviiskaia E, etal. RISE study group. Prevalence of rosacea in the general population of Germany and Russia: The RISE study. J EurAcad Dermatol Venereol 2016; 30 (3): 428-34. DOI: 10.1111/jdv. 13556.
6. Adaskevich VP Acne vulgaris and pink. Moscow: Med. kniga; N. Novgorod: Izd-vo NGMA, 2005; 160 p.
7. Potekaev NN, Aravijskaya ER, Sokolovskij EV, et al. Acne and rosacea. Moscow: Binom; 2007; 216 p.
8. Abram К, Silm Н, Oona М. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Derm Venereol 2010; 90 (3): 269-73. DOI: 10.2340/00015555-0856.
9. Grashkina IG, Grashkin VA, Uts SR. Studying of a wave activity condition and cellular metabolism of tissues in patients with perioral dermatitis. Saratov Journal of Medical Scientific Research 2012; 8 (2): 611-5.
10. Tempark Т, Shwayder ТА. Perioral dermatitis: а review of the condition with special attention to treatment options. Am J Clin Dermatol 2014; 15 (2): 101-13. DOI: 10.1007/S40257-014-0067-7.
11. Olisova OYu, Gromova SA. Perioral dermatitis. Russian Medical Journal 2003; 11 (17): 972-5.
12. Bohm D, Schwanitz Р, Stock Gissendanner S, et al. Symptom severity and psychological sequelae in rosacea:
results of a survey. Psychol Health Med 2014; 19 (5): 586-91. DOI: 10.1080/13548506.2013.841968.
13. Fitzpatrick ТВ. The validity and practicality of sun-reactive skin type I through VI (Editorial). Arch Dermatol 1988; 124 (6): 869-71. DOI: 10.1001 /archderm. 1988.01670060015008.
14. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 2002; 46 (4): 584-7. DOI: 10.1067/mjd. 2002.120625.
15. WollenbergA., Oppel T. Scoring of skin lesions with the Perioral Dermatitis Severity index (PODSI). Acta Derm Venereol 2006; 3 (86): 251-2. DOI: 10.2340/00015555-0044.
16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) — a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19 (3): 210-6. DOI: 10.1111 /j. 1365-2230.1994. tb01167. x.
| Attachment | Size |
|---|---|
| 2020_01_034-038.pdf | 450.92 KB |
Русский
English